510(k) K213049

STIMPOD NMS450 Nerve Stimulator by Xavant Technology (Pty), Ltd. — Product Code BXN

K213049 is an FDA 510(k) premarket notification submitted by Xavant Technology (Pty), Ltd. for the device "STIMPOD NMS450 Nerve Stimulator". The FDA issued a decision of Substantially Equivalent on October 16, 2022. The device falls under product code BXN (Stimulator, Nerve, Battery-Powered), a Class II device regulated under 21 CFR 868.2775. Xavant Technology (Pty), Ltd. has at least 6 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 16, 2022
Date Received
September 22, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Stimulator, Nerve, Battery-Powered
Device Class
Class II
Regulation Number
868.2775
Review Panel
AN
Submission Type